The Groshong catheter as an intraperitoneal access device in the treatment of ovarian cancer patients.
With the development of new intraperitoneal treatments in ovarian cancer, safe and convenient access to the peritoneal cavity is now required. This report reviews the University of Alabama at Birmingham's experience with the Groshong catheter as an intraperitoneal access device. The Groshong was easily inserted intraperitoneally in 20 ovarian cancer patients and used to deliver 81 courses of intraperitoneal therapy over 2310 patient-days. There were no catheter-related complications during treatment and only one exit site infection after catheter removal. Further investigation of the Groshong catheter as a novel intraperitoneal access device appears warranted.
Naumann
R W
RW
Department of Obstetrics and Gynecology, University of Alabama at Birmingham 35233-7333.
Alvarez
R D
RD
Partridge
E E
EE
Kilgore
L C
LC
Austin
J M
JM
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D002404:Catheterization / Q000379:methods*; D002408:Catheters, Indwelling; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral / Q000295:instrumentation; D010535:Laparoscopy; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000601:surgery; D010537:Peritoneum; D012086:Reoperation; D012189:Retrospective Studies
D000970:Antineoplastic Agents